Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 17, 1998

View Archived Issues

rAAV vector to be evaluated for cardiovascular gene transfer

The role of dopamine D2 receptor in alcohol intake suppression

Elan announces completion of private placement for new company

Idec Pharmaceuticals: Q4 and FY 1997 highlights

CellCept evaluated in the clinic for another new indication

Phase III European trial results reinforce potential value of anti-LFA-1 MAb

Vical: Q4 and FY 1997 highlights

NanoSystems to develop new formulation of Boehringer Ingelheim drug

Transkaryotic Therapies: Q4 and FY 1997 highlights

IND approved for new formulation of lidocaine

Lead compounds identified in Warner-Lambert/Trega collaboration

Avigen: Q2 1998 highlights

New formulation of FK-506 demonstrates superior efficacy

Novel immunosuppressive extract magnifies the efficacy of ciclosporin in vitro

Immunosuppressive profile of activity of PS-64 extract

New GnRH antagonists from Merck & Co.

SmithKline Beecham discovers nonpeptide G-CSF mimetics

Dual inhibitors of PDE IV and TNF production prepared at Chiroscience

Warner-Lambert reveals new protein farnesyltransferase inhibitors

Natural insulin secretagogue with potential in NIDDM

rhIL-11 sees first launch

First launch for Zenapax

Femara: second-line treatment option for advanced breast cancer

Bio-Technology General licenses hepatitis B vaccine

Effects of RX-871024 on Ca2+ evaluated in mouse pancreatic beta-cells

tPA associated with neurotoxic effects in acute model of stroke

SIDDCO expands combinatorial chemistry consortium

Therexsys acquires new technology and proposes new company name

Patients sought for GS-4104 clinical study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.